Announcements Trials
Browse Landscape

Phase

Phase NA 2Phase 4 1Phase 3 1

Status

Completed 2Unknown 1Not yet recruiting 1

Sponsor Class

OTHER 63INDUSTRY 15NIH 5OTHER_GOV 4NETWORK 1

Study Type

Interventional 4

Sponsor

Cancer Type

Breast 2

Conditions

Breast Neoplasms 2Polycystic Ovary Syndrome 1Neoplasms, Hormone-Dependent 1

Interventions

Cisplatin 49Capecitabine 41apatinib 34Gemcitabine 33Oxaliplatin 32Cyclophosphamide 31Radiotherapy 29Paclitaxel 29Carboplatin 29tislelizumab 27Irinotecan 27Drug Therapy 27Fluorouracil 26Docetaxel 26Bevacizumab 23fludarabine 18Surgical Procedures, Operative 17Nivolumab 17pembrolizumab 16Exercise 16Metformin 15camrelizumab 14S 1 (combination) 14Radiation 14Pemetrexed 13Control Groups 12anlotinib 11Leucovorin 11toripalimab 10Vinorelbine 10

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
OTHER_GOV × Interventional × Aromatase Inhibitors × Clear all
NCT07379502 2026-01-30

Endometrial Response in Polycystic Ovarian Syndrome Treated With Letrozole Alone or With Added Estradiol Valerate

CMH Kharian Medical College

Phase NA Not yet recruiting
60 enrolled

Polycystic Ovary Syndrome

NCT02701348 2021-08-06

BARONET

NHS Tayside

Phase NA Completed
31 enrolled
Breast

Breast Neoplasms

NCT02995772 2019-06-19

Neoadjuvant Hormonal Therapy Compared to Neoadjuvant Chemotherapy in Stage IIIB/C and IV Breast Cancer Patients

Dharmais National Cancer Center Hospital

Phase 3 Completed
122 enrolled
Breast

Breast Neoplasms

NCT03111615 2017-12-05

HOTBreast

Centro Hospitalar Lisboa Ocidental

Phase 4 Unknown
90 enrolled

Neoplasms, Hormone-Dependent

Data powered by HemOnc (CC BY 4.0) Colophon âš¡